These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23486467)

  • 1. The soluble form of LR11 protein is a regulator of hypoxia-induced, urokinase-type plasminogen activator receptor (uPAR)-mediated adhesion of immature hematological cells.
    Nishii K; Nakaseko C; Jiang M; Shimizu N; Takeuchi M; Schneider WJ; Bujo H
    J Biol Chem; 2013 Apr; 288(17):11877-86. PubMed ID: 23486467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of LR11 Attenuates Hypoxia-Induced Pulmonary Arterial Smooth Muscle Cell Proliferation With Medial Thickening in Mice.
    Jiang L; Konishi H; Nurwidya F; Satoh K; Takahashi F; Ebinuma H; Fujimura K; Takasu K; Jiang M; Shimokawa H; Bujo H; Daida H
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1972-9. PubMed ID: 27493099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LR11, an LDL receptor gene family member, is a novel regulator of smooth muscle cell migration.
    Zhu Y; Bujo H; Yamazaki H; Ohwaki K; Jiang M; Hirayama S; Kanaki T; Shibasaki M; Takahashi K; Schneider WJ; Saito Y
    Circ Res; 2004 Apr; 94(6):752-8. PubMed ID: 14764453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced expression of the LDL receptor family member LR11 increases migration of smooth muscle cells in vitro.
    Zhu Y; Bujo H; Yamazaki H; Hirayama S; Kanaki T; Takahashi K; Shibasaki M; Schneider WJ; Saito Y
    Circulation; 2002 Apr; 105(15):1830-6. PubMed ID: 11956127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G-CSF induces the release of the soluble form of LR11, a regulator of myeloid cell mobilization in bone marrow.
    Shimizu N; Nakaseko C; Jiang M; Nishii K; Yokote K; Iseki T; Higashi M; Tamaru J; Schneider WJ; Bujo H
    Ann Hematol; 2014 Jul; 93(7):1111-22. PubMed ID: 24577511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LR11/SorLA links triglyceride-rich lipoproteins to risk of developing cardiovascular disease in FH patients.
    Vongpromek R; Bujo H; Hoekstra M; Schneider WJ; van der Zee L; Schinkel AF; Korporaal SJ; Dik WA; Ebinuma H; Jiang M; Verhoeven AJ; Sijbrands EJ; Mulder MT
    Atherosclerosis; 2015 Dec; 243(2):429-37. PubMed ID: 26520897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ang II-stimulated migration of vascular smooth muscle cells is dependent on LR11 in mice.
    Jiang M; Bujo H; Ohwaki K; Unoki H; Yamazaki H; Kanaki T; Shibasaki M; Azuma K; Harigaya K; Schneider WJ; Saito Y
    J Clin Invest; 2008 Aug; 118(8):2733-46. PubMed ID: 18618022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetraspanin CD9 modulates ADAM17-mediated shedding of LR11 in leukocytes.
    Tsukamoto S; Takeuchi M; Kawaguchi T; Togasaki E; Yamazaki A; Sugita Y; Muto T; Sakai S; Takeda Y; Ohwada C; Sakaida E; Shimizu N; Nishii K; Jiang M; Yokote K; Bujo H; Nakaseko C
    Exp Mol Med; 2014 Apr; 46(4):e89. PubMed ID: 24699135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mosaic receptor sorLA/LR11 binds components of the plasminogen-activating system and platelet-derived growth factor-BB similarly to LRP1 (low-density lipoprotein receptor-related protein), but mediates slow internalization of bound ligand.
    Gliemann J; Hermey G; Nykjaer A; Petersen CM; Jacobsen C; Andreasen PA
    Biochem J; 2004 Jul; 381(Pt 1):203-12. PubMed ID: 15053742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia inducible factor-1 mediates upregulation of urokinase-type plasminogen activator receptor gene transcription during hypoxia in cervical cancer cells.
    Nishi H; Sasaki T; Nagamitsu Y; Terauchi F; Nagai T; Nagao T; Isaka K
    Oncol Rep; 2016 Feb; 35(2):992-8. PubMed ID: 26718775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating soluble LR11/SorLA levels are highly increased and ameliorated by chemotherapy in acute leukemias.
    Sakai S; Nakaseko C; Takeuchi M; Ohwada C; Shimizu N; Tsukamoto S; Kawaguchi T; Jiang M; Sato Y; Ebinuma H; Yokote K; Iwama A; Fukamachi I; Schneider WJ; Saito Y; Bujo H
    Clin Chim Acta; 2012 Oct; 413(19-20):1542-8. PubMed ID: 22750733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Novel biomarker for pathological immature cells--soluble form of LR11].
    Bujo H
    Rinsho Byori; 2012 May; 60(5):469-76. PubMed ID: 22774576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble form of LR11 is highly increased in the vitreous fluids of patients with idiopathic epiretinal membrane.
    Hashimoto R; Jiang M; Shiba T; Hiruta N; Takahashi M; Higashi M; Hori Y; Bujo H; Maeno T
    Graefes Arch Clin Exp Ophthalmol; 2017 May; 255(5):885-891. PubMed ID: 28102455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating LR11 is a novel soluble-receptor marker for early-stage clinical conditions in patients with non-Hodgkin's lymphoma.
    Fujimura K; Ebinuma H; Fukamachi I; Ohwada C; Kawaguchi T; Shimizu N; Takeuchi M; Sakaida E; Jiang M; Nakaseko C; Bujo H
    Clin Chim Acta; 2014 Mar; 430():48-54. PubMed ID: 24394293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia Promotes Extravillous Trophoblast Cell Invasion through the Hypoxia-Inducible Factor Urokinase-Type Plasminogen Activator Receptor Pathway.
    Shigemitsu A; Naruse K; Kobayashi H
    Gynecol Obstet Invest; 2022; 87(3-4):232-241. PubMed ID: 35785760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional regulation of urokinase-type plasminogen activator receptor by hypoxia-inducible factor 1 is crucial for invasion of pancreatic and liver cancer.
    Büchler P; Reber HA; Tomlinson JS; Hankinson O; Kallifatidis G; Friess H; Herr I; Hines OJ
    Neoplasia; 2009 Feb; 11(2):196-206. PubMed ID: 19177204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia stimulates urokinase receptor expression through a heme protein-dependent pathway.
    Graham CH; Fitzpatrick TE; McCrae KR
    Blood; 1998 May; 91(9):3300-7. PubMed ID: 9558386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levels of soluble LR11/SorLA are highly increased in the bile of patients with biliary tract and pancreatic cancers.
    Terai K; Jiang M; Tokuyama W; Murano T; Takada N; Fujimura K; Ebinuma H; Kishimoto T; Hiruta N; Schneider WJ; Bujo H
    Clin Chim Acta; 2016 Jun; 457():130-6. PubMed ID: 27079357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of measuring soluble LR11, a circulating marker of atherosclerosis and HbA1c in familial hypercholesterolemia.
    Nohara A; Kobayashi J; Kawashiri MA; Tada H; Inazu A; Jiang M; Mabuchi H; Bujo H
    Clin Biochem; 2014 Sep; 47(13-14):1326-8. PubMed ID: 24859021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pitavastatin attenuates the PDGF-induced LR11/uPA receptor-mediated migration of smooth muscle cells.
    Jiang M; Bujo H; Zhu Y; Yamazaki H; Hirayama S; Kanaki T; Shibasaki M; Takahashi K; Schneider WJ; Saito Y
    Biochem Biophys Res Commun; 2006 Oct; 348(4):1367-77. PubMed ID: 16919601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.